Cystic fibrosis-related diabetes and lung disease: an update

The development of cystic fibrosis-related diabetes (CFRD) often leads to poorer outcomes in patients with cystic fibrosis including increases in pulmonary exacerbations, poorer lung function and early mortality. This review highlights the many factors contributing to the clinical decline seen in patients diagnosed with CFRD, highlighting the important role of nutrition, the direct effect of hyperglycaemia on the lungs, the immunomodulatory effects of high glucose levels and the potential role of genetic modifiers in CFRD.

Source: European Respiratory Review - February 16, 2021 Category: Respiratory Medicine Authors: Prentice, B. J., Jaffe, A., Hameed, S., Verge, C. F., Waters, S., Widger, J. Tags: CF and non-CF bronchiectasis Reviews Source Type: research